Semaglutide vs Tesofensine.
Quick Verdict
Semaglutide is a glp-1 agonist primarily researched for fat loss, appetite control, cardiovascular benefits, while Tesofensine is a small molecule studied for extreme fat loss and appetite suppression without glp-1 side effects. A key distinction: Semaglutide has FDA approval status.
Side-by-Side Analysis
| Dimension | Semaglutide | Tesofensine |
|---|---|---|
| Category | GLP-1 Agonist | Small Molecule |
| Mechanism | GLP-1 receptor agonism mimics the incretin hormone to reduce appetite, slow gastric emptying, improve insulin sensitivity, and provide cardiovascular protection. | Triple monoamine reuptake inhibitor (inhibits reuptake of serotonin, noradrenaline, and dopamine). |
| Half-Life | ~7 days | ~9 days |
| Route | SubQ | Oral |
| Typical Dose | 250–250 mcg | 250–500 mcg |
| Frequency | 1x/wk | Daily |
| Evidence Level | Very Strong | Strong |
| Indexed Studies | 20+ indexed | 20+ indexed |
| FDA Status | Approved | Research Only |
| Lowest Price | $47.99 / 5mg via Amino Club | — |
Mechanism of Action Comparison
How Semaglutide Works
Semaglutide Semaglutide is an FDA-approved GLP-1 receptor agonist used to treat type 2 diabetes (Ozempic) and obesity (Wegovy), reducing appetite and improving blood sugar control.
GLP-1 receptor agonism mimics the incretin hormone to reduce appetite, slow gastric emptying, improve insulin sensitivity, and provide cardiovascular protection.
How Tesofensine Works
Tesofensine Tesofensine is an investigational triple monoamine reuptake inhibitor originally developed for Alzheimer's disease, studied for powerful appetite suppression and weight loss exceeding 10% in 24 weeks.
Triple monoamine reuptake inhibitor (inhibits reuptake of serotonin, noradrenaline, and dopamine). Originates as an Alzheimer's/Parkinson's drug but abandoned due to massive weight loss profiles.
Key Mechanistic Difference
Semaglutide operates as a glp-1 agonist, while Tesofensine functions as a small molecule — these are fundamentally different pharmacological approaches.
Research Evidence
Semaglutide
20 studies- STEP 1: Semaglutide 2.4 mg for weight managementWilding et al. (NEJM): Landmark STEP 1 trial semaglutide 2.4mg achieved 14.9% mean weight loss vs 2.4% placebo at 68 w…Very Strong
- SELECT trial: semaglutide reduces cardiovascular events by 20%Lincoff et al. (NEJM): SELECT trial shows semaglutide 2.4mg reduces major adverse cardiovascular events by 20% in overwe…Very Strong
- STEP program overview: pooled Phase 3 weight loss dataComprehensive analysis across STEP trials showing 14.9-17.4% weight loss, improved cardiometabolic risk factors, blood p…Very Strong
Tesofensine
20 studies- Tesofensine induces profound weight lossPhase 2 Lancet study showing 12.8 kg (10.6%) weight loss over 24 weeks at 1mg dose.…Strong
- Tesofensine--a novel potent weight loss medicine. Evaluation of: Astrup A, Breum L, Jensen TJ, Kroustrup JP, Larsen TM. Effect of tesofensine on bodyweight loss, body composition, and quality of life in obese patients: a randomised, double-blind, placebo-controlled trial. Lancet 2008;372:1906-13.A study published in Expert opinion on investigational drugs investigating the effects and mechanisms.…Moderate
- Weight loss produced by tesofensine in patients with Parkinson's or Alzheimer's disease.A study published in Obesity (Silver Spring, Md.) investigating the effects and mechanisms.…Moderate
Vendor Pricing
· Affiliate links · Prices verified 2026Semaglutide
2 vendorsTesofensine
Affiliate disclosure: PeptiDex may earn a commission from purchases via vendor links at no extra cost to you. See our methodology.
Frequently Asked Questions
Can I take Semaglutide and Tesofensine together?▼
No direct interaction data is available for this specific pair. They target different receptor systems, suggesting they could potentially be combined, but no published protocol validates this combination.
Which has more research evidence — Semaglutide or Tesofensine?▼
Semaglutide has 20 indexed studies (highest evidence: Very Strong). Tesofensine has 20 indexed studies (highest evidence: Strong). Both have comparable research coverage.
Which is better for fat loss — Semaglutide or Tesofensine?▼
Both are researched for fat loss. Semaglutide addresses this via fat loss, appetite control, cardiovascular benefits. Tesofensine approaches it through extreme fat loss and appetite suppression without glp-1 side effects. The optimal choice depends on your specific research protocol and which mechanism aligns with your objectives.
Is Semaglutide or Tesofensine FDA-approved?▼
Semaglutide has FDA approval (or is derived from an FDA-approved compound). Tesofensine is a research compound without FDA approval for human use. FDA status reflects regulatory evaluation — not necessarily superiority for all research applications.
Related Comparisons
Deep Dive Profiles
Research Use Only — Not Medical Advice
This comparison is provided for educational and research purposes only. It does not constitute medical, prescribing, or treatment advice. Clinical data cited here is sourced from published peer-reviewed trials and FDA labels. Consult a qualified healthcare professional before making any decisions about medications or research compounds. PeptiDex is an informational resource and does not sell pharmaceutical products.